The authors further demonstrated that TMPRSS2 inhibition by hepatocyte growth factor activator inhibitor-2 abrogates the TMPRSS2-induced invasion of the prostate cancer cells and that activated matriptase levels correlate with TMPRSS2 expression in LNCaP and VCaP prostate cancer cells [268]. Here, SPINT2 is linked to prostate carcinoma.